Fetal acoustic stimulation testing: a retrospective experience with the fetal acoustic stimulation test.
The nonstress test is of accepted value in the surveillance of high-risk pregnancies. In order to improve the efficiency of testing, the authors retrospectively evaluated the adjunctive use of acoustic stimulation testing (FAS-TEST) in 1241 patients who underwent 3464 antepartum fetal heart rate tests. The results were compared to those in the previous 6 months during which time 1307 patients underwent 3573 nonstress tests. The frequency of nonreactive tests was 12.6% in the nonstress test group and 6.1% in those patients who underwent the FAS-TEST. The antepartum fetal death rates were not significantly different when the two groups were compared. The FAS-TEST decreases the percentage of nonreactive tests in a high-risk population and, as a consequence, may reduce the testing time.